Scientists Use Antispam Technology in AIDS Vaccine Work


By Stacy Cowley IDG News Service, New York Bureau
(02/23/05)—Microsoft Corp. researchers are targeting computer algorithms developed for fighting spam at a very different enemy: HIV, the forerunner of the AIDS (Acquired Immune Deficiency Syndrome) disease.

Two Microsoft computer scientists, David Heckerman and Nebojsa Jojic, are part of a team presenting Wednesday at a Boston AIDS research conference an overview of their work on using software programs to uncover patterns in HIV (Human Immunodeficiency Virus) genetic mutation. The pair are collaborating with bioengineers from Australia's Royal Perth Hospital and the University of Washington in Seattle to examine HIV's wild mutation patterns, a better understanding of which researchers see as a key step toward developing broadly effective AIDS vaccines.

Microsoft uses complex data-mining tools to help its Outlook e-mail software and Hotmail e-mail service comb through the vast torrent of incoming messages to separate spam from legitimate e-mail. With spammers ever-adjusting their messages to beat automated filters, spam-detection tools also need to dynamically evolve and flexibly seek out changing patterns.

The catalyst for the alliance between Microsoft's researchers and medical scientists was the idea that software designed to link "VIAGRA" and "V1AGXA" might also be adept at tracking DNA sequence mutations. If scientists can find stable sequences that persist through multiple HIV strains, they can more effectively craft vaccines to target those areas.

Simon Mallal, executive director of the Royal Perth Hospital's Centre for Clinical Immunology and Biomedical Statistics, credits Microsoft's technology with enabling the medical research team to sift through patient data 10 times faster than any previous research technique.

The group's vaccine designs are currently undergoing laboratory testing at Perth and the University of Washington, using immune cell samples taken from HIV-infected patients. Researchers expect to release initial results later this year, but they're already optimistic about the research technique, suggesting it could also be used for work on hepatitis C and other mutating viruses.






Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.